Skip to main content

Advertisement

SpringerLink
Log in

Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Diabetes-induced damages in brain are known as diabetic encephalopathy, which is well characterized by cellular, molecular and functional changes in the brain of diabetic subjects and rodents. However, little is known about the mechanism of damages and the therapeutic strategies in ameliorating those damages in the diabetic brain. In this study, we utilized a flavonoid, morin which is emerging as a potent drug against a wide range of free radical-mediated as well as neurodegenerative diseases. Morin (15 and 30 mg/kg body weight/day) was orally administered to two different groups of rats after 1 week of diabetes induction, and continued for five consecutive weeks. Two other untreated groups of diabetic and non-diabetic rats were used to compare with drug-treated groups. After drug treatments, cerebral cortex of the brain harvested and analyzed for different factors. Morin supplementation especially at high dose increased the levels of insulin, reduced glutathione, superoxide dismutase and catalase activities, and decreased fasting glucose and thiobarbituric acid reactive substances in the diabetic brain compared to untreated diabetic rats (P < 0.05). Morin also significantly decreased the level of inflammatory markers (TNFα, IL1β, IL-6) in the diabetic brain compared to untreated diabetic rats. Furthermore, the drug influenced an increase in the level of neurotrophic factors (BDNF, NGF and IGF-1) in the diabetic brain compared to untreated diabetic rats (P < 0.05). Thus, our results indicate a beneficial effect of morin by decreasing oxidative stress, inflammation and increasing the neurotrophic support in the diabetic brain, which may ameliorate diabetic encephalopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ola MS, Nawaz MI, Siddiquei MM et al (2012) Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complicat 26:56–64

    Article  PubMed  Google Scholar 

  2. Ola MS, Nawaz MI, Khan HA et al (2013) Neurodegeneration and neuroprotection in diabetic retinopathy. Int J Mol Sci 14:2559–2572

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Sun YM, Su Y, Li J et al (2013) Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun 433:359–361

    Article  CAS  PubMed  Google Scholar 

  4. Navaratna D, Guo SZ, Hayakawa K et al (2011) Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes 60:1789–1796

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Francis GJ, Martinez JA, Liu WQ et al (2008) Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain 131:3311–3334

    Article  PubMed  Google Scholar 

  6. Reagan LP, Magariños AM, McEwen BS (2000) Neurological changes induced by stress in streptozotocin diabetic rats. Nature 404:787–790

    Article  Google Scholar 

  7. Acar A, Akil E, Alp H et al (2012) Oxidative damage is ameliorated by curcumin treatment in brain and sciatic nerve of diabetic rats. Int J Neurosci 122:367–372

    Article  CAS  PubMed  Google Scholar 

  8. Prabhakar O (2013) Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 386(8):705–710

    Article  CAS  PubMed  Google Scholar 

  9. Li ZG, Zhang W, Sima AA (2005) The role of impaired insulin/IGF action in primary diabetic encephalopathy. Brain Res 1037:12–24

    Article  CAS  PubMed  Google Scholar 

  10. Tirassa P, Maccarone M, Florenzano F et al (2013) Vascular and neuronal protection induced by the ocular administration of nerve growth factor in diabetic-induced rat encephalopathy. CNS Neurosci Ther 19:307–318

    Article  CAS  PubMed  Google Scholar 

  11. Nitta A, Murai R, Suzuki N et al (2002) Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol 24:695–701

    Article  CAS  PubMed  Google Scholar 

  12. Sposato V, Manni L, Chaldakov GN et al (2007) Streptozotocin-induced diabetes is associated with changes in NGF levels in pancreas and brain. Arch Ital Biol 145:87–97

    CAS  PubMed  Google Scholar 

  13. Abuohashish HM, Al-Rejaie SS, Al-Hosaini KA et al (2013) Alleviating effects of morin against experimentally-induced diabetic osteopenia. Diabetol Metab Syndr 5:5

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Prahalathan P, Kumar S, Raja B (2012) Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation. Metabolism 61:1087–1099

    Article  CAS  PubMed  Google Scholar 

  15. Fang SH, Hou YC, Chang WC et al (2003) Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci 74:743–756

    Article  CAS  PubMed  Google Scholar 

  16. Aleisa AM, Al-Rejaie SS, Abuohashish HM et al (2013) Nephro-protective role of morin against experimentally induced diabetic retinopathy. Digest J Nanomaterials Biostructureol 8:395–401

    Google Scholar 

  17. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205

    Article  CAS  PubMed  Google Scholar 

  18. Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189–195

    Article  CAS  PubMed  Google Scholar 

  19. Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 673–684

  20. Huang M, Gao L, Yang L et al (2012) Abnormalities in the brain of streptozotocin-induced type 1 diabetic rats revealed by diffusion tensor imaging. Neuroimage Clin 1:57–65

    Article  PubMed Central  PubMed  Google Scholar 

  21. Ola MS, Ahmed MM, Abuohashish HM et al (2013) Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats. Neurochem Res 38:1572–1579

    Article  CAS  PubMed  Google Scholar 

  22. Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 17:97

    Article  Google Scholar 

  23. Chen WP, Wang YL, Tang JL et al (2012) Morin inhibits interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Int Immunopharmacol 12:447–452

    Article  CAS  PubMed  Google Scholar 

  24. Manna SK, Aggarwal RS, Sethi G et al (2007) Morin (3,5,7,2′,4′-pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis. Clin Cancer Res 13:2290–2297

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Li R, Huang YG, Fang D et al (2004) (−)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res 78:723–731

    Article  CAS  PubMed  Google Scholar 

  26. Xu SL, Bi CW, Choi RC et al (2013) Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor. Evid Based Complement Alternat Med 2013:127075

    PubMed Central  PubMed  Google Scholar 

  27. De Nicoló S, Tarani L, Ceccanti M et al (2013) Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain. Nutrition 29:681–687

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to extend their sincere appreciation to Deanship of Scientific Research at King Saud University for its funding of this research through the Research Project No. RGP-VPP-263.

Author information

Authors and Affiliations

  1. Department of Biochemistry, College of Science, King Saud University, Riyadh, 11415, Saudi Arabia

    Mohammad S. Ola & Abdullah S. Alhomida

  2. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University Riyadh, Riyadh, Saudi Arabia

    Abdulaziz M. Aleisa, Salim S. Al-Rejaie, Hatem M. Abuohashish, Mihir Y. Parmar & Mohammed M. Ahmed

Authors
  1. Mohammad S. Ola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdulaziz M. Aleisa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salim S. Al-Rejaie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hatem M. Abuohashish
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mihir Y. Parmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abdullah S. Alhomida
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mohammed M. Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammad S. Ola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ola, M.S., Aleisa, A.M., Al-Rejaie, S.S. et al. Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol Sci 35, 1003–1008 (2014). https://doi.org/10.1007/s10072-014-1628-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1628-5

Keywords

Search

Navigation